Lon Cardon - Dec 19, 2022 Form 3 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
Director
Signature
/s/ Jody Howe, Attorney-in-Fact
Stock symbol
MIRM
Transactions as of
Dec 19, 2022
Transactions value $
$0
Form type
3
Date filed
12/19/2022, 08:22 PM
Next filing
Jun 14, 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.